236 related articles for article (PubMed ID: 11899153)
1. Risk of second primary malignancies in patients with cutaneous melanoma.
Schmid-Wendtner MH; Baumert J; Wendtner CM; Plewig G; Volkenandt M
Br J Dermatol; 2001 Dec; 145(6):981-5. PubMed ID: 11899153
[TBL] [Abstract][Full Text] [Related]
2. Second malignancies in melanoma patients in Thuringia.
Wolff J; Wollina U
J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):479-83. PubMed ID: 11444270
[TBL] [Abstract][Full Text] [Related]
3. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
4. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.
Gassenmaier M; Stec T; Keim U; Leiter U; Eigentler TK; Metzler G; Garbe C
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):63-70. PubMed ID: 30051517
[TBL] [Abstract][Full Text] [Related]
5. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
6. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.
Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838
[TBL] [Abstract][Full Text] [Related]
7. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
[TBL] [Abstract][Full Text] [Related]
8. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance.
Guitera P; Menzies SW; Coates E; Azzi A; Fernandez-Penas P; Lilleyman A; Badcock C; Schmid H; Watts CG; Collgros H; Liu R; van Kemenade C; Mann GJ; Cust AE
JAMA Dermatol; 2021 May; 157(5):521-530. PubMed ID: 33729464
[TBL] [Abstract][Full Text] [Related]
10. Second primary tumors in patients with cutaneous malignant melanoma.
Bhatia S; Estrada-Batres L; Maryon T; Bogue M; Chu D
Cancer; 1999 Nov; 86(10):2014-20. PubMed ID: 10570426
[TBL] [Abstract][Full Text] [Related]
11. Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
13. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
14. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients.
Schmid-Wendtner MH; Baumert J; Stange J; Volkenandt M
Melanoma Res; 2002 Aug; 12(4):389-94. PubMed ID: 12170189
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
Moore MM; Geller AC; Warton EM; Schwalbe J; Asgari MM
J Am Acad Dermatol; 2015 Oct; 73(4):630-6. PubMed ID: 26298295
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract][Full Text] [Related]
17. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
18. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
[TBL] [Abstract][Full Text] [Related]
19. Second primary melanomas: incidence and outcome.
Bower MR; Scoggins CR; Martin RC; Mays MP; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Noyes RD; Sussman JJ; Hagendoorn LJ; Stromberg AJ; McMasters K
Am Surg; 2010 Jul; 76(7):675-81. PubMed ID: 20698369
[TBL] [Abstract][Full Text] [Related]
20. Value of ultrasonography compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma.
Schmid-Wendtner MH; Paerschke G; Baumert J; Plewig G; Volkenandt M
Melanoma Res; 2003 Apr; 13(2):183-8. PubMed ID: 12690303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]